Clinical trial
Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic…
NCT00470340 · Assistance Publique - Hôpitaux de Paris, Other · Terminated
Key facts
| NCT number | NCT00470340 |
|---|---|
| Title | Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients |
| Official title | Arterial LIPIODOLISED Chemotherapy Versus Systemic Chemotherapy With Gemcitabine Plus Oxaliplatin (GEMOX) Versus no Treatment Following Surgical Resection or Local Ablation of Hepatocellular Carcinoma in Cirrhotic Patients |
| Acronym | GEMOXIAL |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Liver Neoplasms, Liver Cirrhosis, Carcinoma, Hepatocellular, Recurrence, Neoplasm Recurrence, Local |
| Intervention type | Drug |
| Interventions | Oxaliplatin, gemcitabine, cisplatin, lipiodol |
| Enrollment | 263 |
| Start date | Jun 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | May 7, 2007 |
| Last update posted | May 5, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: